(Q53001772)

English

Acute lymphoblastic leukemia in children: nonrandomized comparison of conventional vs. intensive chemotherapy at the National Cancer Institute of Colombia.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/8986146

Acute lymphoblastic leukemia in children: nonrandomized comparison of conventional vs. intensive chemotherapy at the National Cancer Institute of Colombia. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/8986146

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

author name string

Buendia MT

1

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/8986146

Terselich G

2

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/8986146

Lozano JM

3

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/8986146

Viscaino MP

4

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/8986146

publication date

1 February 1997

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/8986146

Pediatric Blood & Cancer

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/8986146

28

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/8986146

2

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/8986146

108-116

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/8986146

Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199702%2928%3A2%3C108%3A%3AAID-MPO4%3E3.0.CO%3B2-O

21 January 2018

Age at diagnosis in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199702%2928%3A2%3C108%3A%3AAID-MPO4%3E3.0.CO%3B2-O

21 January 2018

Survival of children and adolescents with acute lymphoid leukemia. A study of American Indians and Hispanic and non-Hispanic whites treated in New Mexico (1969 to 1986).

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199702%2928%3A2%3C108%3A%3AAID-MPO4%3E3.0.CO%3B2-O

21 January 2018

Proposals for the Classification of the Acute Leukaemias French-American-British (FAB) Co-operative Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199702%2928%3A2%3C108%3A%3AAID-MPO4%3E3.0.CO%3B2-O

21 January 2018

Randomized versus historical controls for clinical trials.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199702%2928%3A2%3C108%3A%3AAID-MPO4%3E3.0.CO%3B2-O

21 January 2018

Developing improved observational methods for evaluating therapeutic effectiveness.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199702%2928%3A2%3C108%3A%3AAID-MPO4%3E3.0.CO%3B2-O

21 January 2018

Childhood leukemias

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199702%2928%3A2%3C108%3A%3AAID-MPO4%3E3.0.CO%3B2-O

21 January 2018

The cribriform plate: a sanctuary site for meningeal leukaemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199702%2928%3A2%3C108%3A%3AAID-MPO4%3E3.0.CO%3B2-O

21 January 2018

Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199702%2928%3A2%3C108%3A%3AAID-MPO4%3E3.0.CO%3B2-O

21 January 2018

Prevention of CNS disease in intermediate-risk acute lymphoblastic leukemia: comparison of cranial radiation and intrathecal methotrexate and the importance of systemic therapy: a Childrens Cancer Group report.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199702%2928%3A2%3C108%3A%3AAID-MPO4%3E3.0.CO%3B2-O

21 January 2018

Clinical relevance of in vitro drug resistance testing in childhood acute lymphoblastic leukemia: the state of the art.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199702%2928%3A2%3C108%3A%3AAID-MPO4%3E3.0.CO%3B2-O

21 January 2018

Leukemias associated with human T-cell lymphotropic virus type I in a non-endemic region

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199702%2928%3A2%3C108%3A%3AAID-MPO4%3E3.0.CO%3B2-O

21 January 2018

Acute lymphoblastic leukemia in childhood.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199702%2928%3A2%3C108%3A%3AAID-MPO4%3E3.0.CO%3B2-O

21 January 2018

Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group Study CCG-106

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199702%2928%3A2%3C108%3A%3AAID-MPO4%3E3.0.CO%3B2-O

21 January 2018

Factors influencing survival in pediatric acute leukemia.The SWCCSG experience, 1958–1970

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199702%2928%3A2%3C108%3A%3AAID-MPO4%3E3.0.CO%3B2-O

21 January 2018

Three versus five years of maintenance therapy are equivalent in childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199702%2928%3A2%3C108%3A%3AAID-MPO4%3E3.0.CO%3B2-O

21 January 2018

Presymptomatic central nervous system therapy in previously untreated childhood acute lymphoblastic leukaemia: comparison of 1800 rad and 2400 rad. A report for Children's Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199702%2928%3A2%3C108%3A%3AAID-MPO4%3E3.0.CO%3B2-O

21 January 2018

Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199702%2928%3A2%3C108%3A%3AAID-MPO4%3E3.0.CO%3B2-O

21 January 2018

CNS leukemia: problem of diagnosis, treatment, and outcome

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199702%2928%3A2%3C108%3A%3AAID-MPO4%3E3.0.CO%3B2-O

21 January 2018

Is the standardized helmet technique adequate for irradiation of the brain and the cranial meninges?

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199702%2928%3A2%3C108%3A%3AAID-MPO4%3E3.0.CO%3B2-O

21 January 2018

Detection of systematic patient setup errors by portal film analysis

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199702%2928%3A2%3C108%3A%3AAID-MPO4%3E3.0.CO%3B2-O

21 January 2018

High-dose methotrexate improves clinical outcome in children with acute lymphoblastic leukemia: St. Jude Total Therapy Study X

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199702%2928%3A2%3C108%3A%3AAID-MPO4%3E3.0.CO%3B2-O

21 January 2018

Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusions for remission induction in relapsed childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199702%2928%3A2%3C108%3A%3AAID-MPO4%3E3.0.CO%3B2-O

21 January 2018

Clinical pharmacodynamics of high-dose methotrexate in acute lymphocytic leukemia. Identification of a relation between concentration and effect

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199702%2928%3A2%3C108%3A%3AAID-MPO4%3E3.0.CO%3B2-O

21 January 2018

Identifiers

10.1002/(SICI)1096-911X(199702)28:2<108::AID-MPO4>3.0.CO;2-O

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/8986146

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 May 2018

http://europepmc.org/abstract/MED/8986146

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53001772&oldid=1586499506"